Niklas Ahlborg is a Senior Advisor at Mabtech AB, where they previously served as Head of Research and Development from 1999 to 2018 and CEO from 2018 to 2022. They completed their PhD at Stockholm University in 1995 and are currently an Associate Professor there. Ahlborg also held postdoctoral positions at both Stockholm University and Edinburgh University, focusing on malaria immunity and vaccines. Their academic journey began with a BSc in Biology/Immunology from Stockholm University, completed in 1988.
This person is not in the org chart
This person is not in any teams
This person is not in any offices